APA (7th ed.) Citation

Huang, R., Jun, D. W., Toyoda, H., Hsu, Y., Trinh, H., Nozaki, A., . . . Nguyen, M. H. (2025). Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues. Clinical and molecular hepatology, 31(3), 1003-1017. https://doi.org/10.3350/cmh.2024.1070

Chicago Style (17th ed.) Citation

Huang, Rui, et al. "Impacts of Metabolic Syndrome Diseases on Long-term Outcomes of Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues." Clinical and Molecular Hepatology 31, no. 3 (2025): 1003-1017. https://doi.org/10.3350/cmh.2024.1070.

MLA (9th ed.) Citation

Huang, Rui, et al. "Impacts of Metabolic Syndrome Diseases on Long-term Outcomes of Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues." Clinical and Molecular Hepatology, vol. 31, no. 3, 2025, pp. 1003-1017, https://doi.org/10.3350/cmh.2024.1070.